The role of platelets in the pathophysiology of atherosclerosis (Review)

Molecular Medicine Reports

Volumn 1, Issue 2, 2008, Pages 179-184

  Palomo, Iván ^a   Toro, Carla ^a   Alarcón, Marcelo ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

Author keywords

Atherosclerosis; Endothelial cells; Platelets; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CD40 ANTIGEN; CD40 LIGAND; CLOPIDOGREL; FIBRINOGEN RECEPTOR; PADGEM PROTEIN; PROCOAGULANT;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL INTERACTION; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; ISCHEMIA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOGENESIS;

EID: 69249156463     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. World Health Organization: Informe sobre la salud en el mundo. Technical Report Series ISBN 92 4 356207X. WHO, Geneva, 2002.
2. Willeit J and Kiechl S: Biology of arterial atheroma. Cerebrovasc Dis 10 (Suppl 5): 1-8, 2000.
3. Vaina S and Stefanadis C: Detection of the vulnerable coronary atheromatous plaque. Where are we now? Int J Cardiovasc Intervent 7: 75-87, 2005.
4. Andrews RK and Berndt MC: Platelet physiology and thrombosis. Thromb Res 114: 447-453, 2004.
5. Santos M, Aranda E, Vallés J and Palomo I: Hemostasia primaria. In: Hematología: Fisiopatología y Diagnóstico. Palomo I, Pereira J and Palma J (eds). Universidad de Talca, Talca, pp459-492, 2005.
6. Altman R, Berg G and Berman S: Trombosis: Fisiología, mecanismos de enfermedad y tratamiento. In: Trombosis: Fisiopatología, Mecanismos de enfermedad y Tratamiento. Altman R (ed). Akadia, pp3-22, 2005.
7. Zhao J, Zhou Q, Wiedmer T and Sims PJ: Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem 273: 6603-6606, 1998. (Pubitemid 28160315)
8. Panes O, Matus V, Saez CG, Quiroga T, Pereira J and Mezzano D: Human platelets synthesize and express functional tissue factor. Blood 109: 5242-5250, 2007. (Pubitemid 46890544)
9. Massberg S, Schulz C and Gawaz M: Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med 3: 147-162, 2003. (Pubitemid 37012741)
10. Siegel-Axel D, Langer H, Lindemann S and Gawaz M: Role of platelets in atherosclerosis and inflammation. Med Klin (Munich) 101: 467-475, 2006.
11. Bombeli T, Schwartz BR and Harlan JM: Adhesion of activated platelets to endothelial cells: evidence for a GPIIb-IIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187: 329-339, 1998. (Pubitemid 28080062)
12. Huo Y, Schober A, Forlow SB, et al: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipo-protein E. Nat Med 9: 61-67, 2003. (Pubitemid 36098261)
13. Blann AD, Nadar SK and Lip GY: The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24: 2166-2179, 2003. (Pubitemid 37522669)
14. Langer H, May AE, Bultmann A and Gawaz M: ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation. Thromb Haemost 94: 555-561, 2005. (Pubitemid 41300852)
15. Frenette PS, Johnson RC, Hynes RO and Wagner DD: Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92: 7450-7454, 1995.
16. Gawaz M, Langer H and May AE: Platelets in inflammation and atherogenesis. J Clin Invest 115: 3378-3384, 2005.
17. Henn V, Slupsky JR, Grafe M, et al: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391: 591-594, 1998. (Pubitemid 28157601)
18. Gawaz M, Brand K, Dickfeld T, et al: Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 148: 75-85, 2000.
19. Hawrylowicz CM, Howells GL and Feldmann M: Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 174: 785-790, 1991.
20. Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA and Dinarello CA: Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81: 2492-2495, 1993.
21. Scheuerer B, Ernst M, Durrbaum-Landmann I, et al: The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95: 1158-1166, 2000. (Pubitemid 30099821)
22. Nassar T, Sachais BS, Akkawi S, et al: Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 278: 6187-6193, 2003. (Pubitemid 36800873)
23. Von Hundelshausen P, Koenen RR, Sack M, et al: Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105: 924-930, 2005. (Pubitemid 40170856)
24. Schober A, Manka D, von Hundelshausen P, et al: Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106: 1523-1529, 2002. (Pubitemid 35050881)
25. Baltus T, von Hundelshausen P, Mause SF, Buhre W, Rossaint R and Weber C: Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J Leukoc Biol 78: 435-441, 2005. (Pubitemid 41061315)
26. Tang J, Kozaki K, Farr AG, et al: The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice. Am J Pathol 167: 901-912, 2005. (Pubitemid 41216372)
27. Rojas A and Morales MA: Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci 76: 715-730, 2004. (Pubitemid 39576147)
28. Verma S, Buchanan MR and Anderson TJ: Endothelial function testing as a biomarker of vascular disease. Circulation 108: 2054-2059, 2003. (Pubitemid 37337577)
29. Rojas A, Romay S, Gonzalez D, Herrera B, Delgado R and Otero K: Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. Circ Res 86: E50-E54, 2000.
30. Willerson JT and Kereiakes DJ: Endothelial dysfunction. Circulation 108: 2060-2061, 2003.
31. Cybulsky MI, Lichtman AH, Hajra L and Iiyama K: Leukocyte adhesion molecules in atherogenesis. Clin Chim Acta 286: 207-218, 1999.
32. Landmesser U, Hornig B and Drexler H: Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost 26: 529-537, 2000.
33. Iiyama K, Hajra L, Iiyama M, et al: Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 85: 199-207, 1999. (Pubitemid 29343319)
34. Bombeli T, Karsan A, Tait JF and Harlan JM: Apoptotic vascular endothelial cells become procoagulant. Blood 89: 2429-2442, 1997. (Pubitemid 27143290)
35. Marcus AJ and Safier LB: Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 7: 516-522, 1993. (Pubitemid 23120898)
36. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO and Wagner DD: The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102: 145-152, 1998.
37. Bombeli T, Schwartz BR and Harlan JM: Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 93: 3831-3838, 1999. (Pubitemid 29249830)
38. Horstman LL, Jy W, Jimenez JJ, Bidot C and Ahn YS: New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53: 210-230, 2004. (Pubitemid 40139594)
39. Tedgui A and Mallat Z: Smooth muscle cells: another source of tissue factor-containing microparticles in atherothrombosis? Circ Res 87: 81-82, 2000.
40. Nomura S: Platelet activation marker. Rinsho Byori 51: 1096-1101, 2003.
41. Brodsky SV, Malinowski K, Golightly M, Jesty J and Goligorsky MS: Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 106: 2372-2378, 2002. (Pubitemid 35244740)
42. Boulanger CM, Scoazec A, Ebrahimian T, et al: Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649-2652, 2001. (Pubitemid 33108128)
43. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM and Tedgui A: Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99: 348-353, 1999. (Pubitemid 29051259)
44. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J and Dignat-George F: Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99: 3962-3970, 2002.
45. Preston RA, Jy W, Jimenez JJ, et al: Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41: 211-217, 2003. (Pubitemid 36204891)
46. Koga H, Sugiyama S, Kugiyama K, et al: Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 27: 817-823, 2006.
47. Falati S, Liu Q, Gross P, et al: Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197: 1585-1598, 2003.
48. Nomura S, Suzuki M, Katsura K, et al: Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 116: 235-240, 1995.
49. Chirinos JA, Heresi GA, Velasquez H, et al: Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 45: 1467-1471, 2005. (Pubitemid 40615620)
50. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR and Weber C: Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 25: 1512-1518, 2005. (Pubitemid 40923377)
51. Izaguirre Avila R, De La Pena A, Gonzalez Pacheco H, et al: Efficacy of clopidogrel as ADP-dependent platelet aggregation inhibitor. Study on individuals with coronary artery disease. Arch Inst Cardiol Mex 70: 472-480, 2000.
52. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329-1339, 1996.
53. Easton JD: Evidence with antiplatelet therapy and ADP-receptor antagonists. Cerebrovasc Dis 16 (Suppl 1): 20-26, 2003.
54. Gu Q, Chen JL and Ruan YM: Inhibitory effects of aspirin, clopidogrel, and their combination on the progression of atherosclerosis in rabbits. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27: 87-91, 2005.
55. Anderson HV, McNatt J, Clubb FJ, et al: Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries. Circulation 104: 2331-2337, 2001. (Pubitemid 33049517)
56. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E and Harder S: Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73: 232-241, 2003. (Pubitemid 36269674)
57. Graff J, Harder S, Wahl O, Scheuermann EH and Gossmann J: Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. Clin Pharmacol Ther 78: 468-476, 2005. (Pubitemid 41698901)
58. Jarvis B and Simpson K: Clopidogrel: a review of its use in the prevention of atherothrombosis. Drugs 60: 347-377, 2000. (Pubitemid 30680398)
59. Jain A, Wadehra V and Timmis AD: Management of stable angina. Postgrad Med J 79: 332-336, 2003.